Scottish Cot Death Trust, University of Glasgow, Glasgow, UK
Population Health Sciences, University of Bristol, Bristol, UK.
Arch Dis Child. 2020 Sep;105(9):864-868. doi: 10.1136/archdischild-2019-318082. Epub 2020 Mar 10.
To assess evidence supporting the view that 'low fibre childhood constipation'.
Triangulation integrated three approaches: a systematic review NICE guideline CG99 examining effectiveness of increasing fibre; a cohort study, Avon Longitudinal Study of Parents and Children (ALSPAC), to assess if constipation (or hard stools) can precede fibre intake at weaning; and a literature search for twin studies to calculate heredity.
CG99 examined the literature regarding the effectiveness of increasing fibre. ALSPAC asked parents about: hard stools at 4 weeks, 6 months and 2.5 years and constipation at age 4-10 years, as well as fibre intake at 2 years. Twin studies and data from ALSPAC were pooled to calculate concordance of constipation comparing monozygotic and dizygous twin pairs.
CG99 reported six randomised controlled trials (RCTs). ALSPAC hard stool data from 6796 children at 4 weeks, 9828 at 6 months and 9452 at 2.5 years plus constipation data on 8401 at 4-10 years were compared with fibre intake at 2 years. Twin studies had 338 and 93 twin pairs and ALSPAC added a further 45.
Increasing fibre did not effectively treat constipation. Hard stools at 4 weeks predated fibre and at 6 months predicted lower fibre intake at 2 years (p=0.003). Heredity explained 59% of constipation.
RCTs indicate that increasing fibre is not an effective treatment for constipation in children. Hard stools can precede and predict later fibre intake. Genetic inheritance explains most childhood constipation. Extended treatment with stool softeners may improve fibre intake and limit long-term damaging sequelae of constipation.
评估支持“儿童低纤维性便秘”观点的证据。
三角测量法整合了三种方法:系统评价 NICE 指南 CG99,研究增加纤维的有效性;一项队列研究,即阿冯纵向父母和儿童研究 (ALSPAC),评估便秘(或硬便)是否可以在断奶前先于纤维摄入;以及对双胞胎研究进行文献检索以计算遗传率。
CG99 检查了关于增加纤维有效性的文献。ALSPAC 询问了父母关于:4 周、6 个月和 2.5 岁时的硬便以及 4-10 岁时的便秘,以及 2 岁时的纤维摄入量。双胞胎研究和 ALSPAC 的数据被合并,以计算比较同卵和异卵双胞胎对便秘的一致性。
CG99 报告了六项随机对照试验 (RCT)。ALSPAC 4 周时的 6796 名儿童、6 个月时的 9828 名儿童和 2.5 岁时的 9452 名儿童的硬便数据,加上 4-10 岁时的 8401 名儿童的便秘数据,与 2 岁时的纤维摄入量进行了比较。双胞胎研究有 338 对和 93 对双胞胎,ALSPAC 又增加了 45 对。
增加纤维并不能有效治疗便秘。4 周时的硬便先于纤维,6 个月时的硬便预测 2 岁时纤维摄入量较低(p=0.003)。遗传因素解释了 59%的便秘。
RCT 表明,增加纤维对儿童便秘不是有效的治疗方法。硬便可以先于并预测以后的纤维摄入。遗传继承解释了大部分儿童便秘。延长使用软便剂的治疗可能会改善纤维摄入并限制便秘的长期损害后果。